Effects of aliskiren on cardiac sympathetic activity in patients with systolic heart failure

Trial Profile

Effects of aliskiren on cardiac sympathetic activity in patients with systolic heart failure

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Nov 2012

At a glance

  • Drugs Aliskiren (Primary) ; Heart failure therapies
  • Indications Heart failure
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 07 Nov 2012 Results presented at the 85th Annual Scientific Sessions of the American Heart Association.
    • 04 Dec 2011 New trial record
    • 16 Nov 2011 Results presented at the 84th Annual Scientific Sessions of the American Heart Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top